Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Form 8.5 (EPT/RI)

13 Aug 2020 11:57

RNS Number : 0806W
Nplus1 Singer Capital Markets Ltd
13 August 2020
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MICROSAIC SYSTEMS PLC

 

(c) Name of the party to the offer with which exempt principal trader is connected:

MICROSAIC SYSTEMS PLC

(d) Date dealing undertaken:

12 August 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.25P

 

 

Purchase

 

100,000

 

0.4651p

 

 

0.4651p

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

13 August 2020

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERKZGMRGFKGGZM
Date   Source Headline
19th Jun 20177:00 amRNSTrading Statement
15th May 201711:42 amRNSResult of AGM
11th May 20177:00 amRNSMicrosaic Enhances Bioprocessing Capabilities
26th Apr 20177:00 amRNSIntegration with SCPA chromatography software
21st Apr 20177:00 amRNSNotice of AGM
7th Apr 20177:00 amRNSAgreement
21st Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSChange of registrar
24th Jan 201712:56 pmRNSAppointment of Interim Chairman
13th Dec 20167:00 amRNSTrading Statement
28th Sep 20167:00 amRNSDirectorate Change
21st Sep 20164:39 pmRNSHolding(s) in Company
16th Sep 20161:44 pmRNSDirector/PDMR Shareholding
15th Sep 20161:03 pmRNSHolding(s) in Company
15th Sep 201610:02 amRNSTR-1: Notification of Major Interest in Shares
14th Sep 20165:23 pmRNSHolding(s) in Company
14th Sep 20163:38 pmRNSGrant of Options
13th Sep 20164:46 pmRNSHolding(s) in Company
13th Sep 201610:45 amRNSHolding(s) in Company
13th Sep 20168:40 amRNSHolding(s) in Company
13th Sep 20168:30 amRNSDirector/PDMR Shareholding
12th Sep 201611:53 amRNSResult of GM, Completion of Placing, TVRs
26th Aug 20164:49 pmRNSResult of Placing
26th Aug 20161:15 pmRNSHalf-year Report
26th Aug 20161:15 pmRNSProposed Placing of New Shares
20th Jun 20163:27 pmRNSAGM Statement
13th Jun 20167:00 amRNSChange of Nominated Adviser and Broker
19th May 20167:00 amRNSDistribution of Annual Report and Accounts
13th May 201612:57 pmRNSAGM Change of Date
16th Mar 20167:00 amRNSAnnual Financial Report
8th Mar 20167:00 amRNSDirectorate Change
24th Feb 20167:00 amRNSTrading Statement
14th Jan 20167:00 amRNSAward of Options
21st Dec 20157:00 amRNSDirectorate Change
2nd Dec 20157:04 amRNSTrading Update & Directorate Change
30th Nov 201511:47 amRNSHolding(s) in Company
23rd Oct 201511:41 amRNSHolding(s) in Company
22nd Oct 20151:12 pmRNSHolding(s) in Company
19th Oct 20151:37 pmRNSResults of EGM and Placing
15th Oct 20157:00 amRNSPlacing - Exercise of Additional Demand Option
13th Oct 20153:30 pmRNSDirector/PDMR Shareholding
30th Sep 20157:44 amRNSPlacing of New Shares
30th Sep 20157:00 amRNSInterim Results
20th May 20157:00 amRNSResult of AGM
8th Apr 20158:34 amRNSNotification of Major Interest in Shares
30th Mar 20157:00 amRNSDistribution of Annual Report and Accounts
23rd Mar 20157:00 amRNSAnnual Financial Report
19th Mar 20157:00 amRNSAppoinment of Chief Operating Officer
16th Mar 20157:00 amRNSOEM Supply Agreement with GE Healthcare
6th Jan 20158:40 amRNSExercise of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.